HB 2375 Summary

• Moves pseudoephedrine products from Schedule V to Schedule III of controlled substances, making them subject to stricter regulation.

• Eliminates specific purchase restrictions for pseudoephedrine products including the 9-gram per 30-day limit, identity verification requirements, and written log documentation previously required at pharmacies.

• Removes reporting and monitoring requirements for dispensers of pseudoephedrine products, including real-time electronic logbook submissions to the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control.

• Deletes provisions related to liquid, liquid capsule, and gel capsule exemptions for pseudoephedrine-containing products.

• Becomes effective November 1, 2012.